Leading the Way in Life Science Technologies

GEN Exclusives

More »
Liver Diseases - Related Content
  • Insight & Intelligence™
  • More »
  • Infographic: Hepatitis C
    September 5, 2014

    This graphic from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) tells you what you need to know about this "silent epidemic".
  • Why Is Everybody Picking on Sovaldi?
    September 3, 2014

    It is highly cost-effective at the $84,000 price, but....

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »